Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Anthony M. Joshua
Based on 31 articles published since 2010
(Why 31 articles?)
||||
Expertise Level
The expertise of Anthony M. Joshua ranks in the
  • Top 0.22%
  • ... of 120,378 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 31 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Joshua, A M   ·   Joshua, Anthony   ·   Joshua, A   ·   Joshua, Anthony M
Work Locations
Details
Most likely:    St. Vincent's Hospital Sydney      
2019
  • Sydney Children's Hospital, Randwick, New South Wales, Australia. · School of Women's and Children's Health, University of New South Wales, Randwick, New South Wales, Australia. · St. Vincent's Hospital, Darlinghurst, New South Wales, Australia. · Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia. · Sydney Eye Hospital, Sydney, New South Wales, Australia. · Kid's Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia. · Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Pubmed 31768361
  • St Vincent's Hospital, Sydney. · St Vincent's Clinical School, UNSW Sydney. · Pubmed 31048940
  • Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Laboratory Medicine, University Health Network, Toronto, Canada. · Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Otolaryngology, Head and Neck Surgery, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Pharmacy, Princess Margaret Cancer Centre, Toronto, Canada. · Drug Development Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · University Health Network, Princess Margaret Cancer Centre, 9-622, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. · Pubmed 30747243
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. · Pubmed 29738114
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
2016
  • Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Astrazeneca plc, Melbourn Science Park, DaVinci Building, Melbourn, United Kingdom. · Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia. · Pubmed 27683208
2019
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. Electronic address: · Department of Dermatology, Gustave Roussy, Villejuif; Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead; Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, Macquarie University, Macquarie Park; Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Medical Oncology, University of Sydney, Sydney, Australia; Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, University of Sydney, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney; Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 31987275
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. · Department of Dermatology, Gustave Roussy, Villejuif. · Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead. · Medical Oncology, Melanoma Institute Australia, Sydney. · Medical Oncology, Macquarie University, Macquarie Park. · Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney. · Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 30715153
Probable:    University of New South Wales      
2019
  • St Vincent's Hospital, Sydney. · St Vincent's Clinical School, UNSW Sydney. · Pubmed 31048940
2018
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
2019
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. Electronic address: · Department of Dermatology, Gustave Roussy, Villejuif; Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead; Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, Macquarie University, Macquarie Park; Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Medical Oncology, University of Sydney, Sydney, Australia; Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, University of Sydney, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney; Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 31987275
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. · Department of Dermatology, Gustave Roussy, Villejuif. · Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead. · Medical Oncology, Melanoma Institute Australia, Sydney. · Medical Oncology, Macquarie University, Macquarie Park. · Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney. · Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 30715153
Probable:    University Health Network of Toronto      
2019
  • Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Laboratory Medicine, University Health Network, Toronto, Canada. · Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Otolaryngology, Head and Neck Surgery, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Pharmacy, Princess Margaret Cancer Centre, Toronto, Canada. · Drug Development Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · University Health Network, Princess Margaret Cancer Centre, 9-622, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. · Pubmed 30747243
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center · Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY · Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris · Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France · Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands · Stephen Frank, Hebrew University Hadassah Medical School - The Sharett Institute of Oncology, Jerusalem · Jacob Schachter, Sheba Medical Center at Tel Hashomer, and Tel-Aviv University Medical School, Tel Aviv, Israel · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Josep M. Piulats, Institut Catala d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Veronique Cocquyt, Ghent University Hospital, Ghent, Belgium · Bartosz Chmielowski, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA · T.R. Jeffry Evans, University of Glasgow, Glasgow · Delyth Clemett, Shirley Spratt, Susan Lovick, and Elaine Kilgour, AstraZeneca, Macclesfield · Dana Ghiorghiu and Gabriella Mariani, AstraZeneca, Cambridge · Paul Nathan, Mt Vernon Cancer Centre, Northwood, United Kingdom · Gerald Linette, Washington University School of Medicine, St Louis, MO · Carola Berking, University Hospital of Munich, Munich, Germany · Peter Barker, AstraZeneca, Gaithersburg, MD · and Zhongwu Lai, AstraZeneca, Waltham, MA. · Pubmed 29528792
  • Caroline Robert, Gustave Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Adil Daud, University of California, San Francisco, San Francisco, CA · Jedd D. Wolchok, Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY · Anthony M. Joshua, The Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H Lee Moffitt Cancer Center, Tampa · Richard W. Joseph, Mayo Clinic Cancer Center-Florida, Jacksonville, FL · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, UPMC Hillman Cancer Center, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead · Melanoma Institute Australia, Wollstonecraft · and Macquarie University, MQ Health, Health Sciences Centre · Peter Hersey, University of Sydney, Sydney, New South Wales, Australia · Jin Zhang, James Anderson, Scott J. Diede, and Scot Ebbinghaus, Merck & Co., Inc., Kenilworth, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 29283791
2017
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, NY, USA. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · Mayo Clinic, Rochester, MN, USA. · University of Iowa Carver College of Medicine, Iowa City, IA, USA. · Princess Margaret Hospital University Health Network, Toronto, ON, Canada. · Penn Medicine, Philadelphia, PA, USA. · University of Chicago, Chicago, IL, USA. · Mount Sinai Medical Center, Miami Beach, FL, USA. · University of Michigan, Ann Arbor, MI, USA. · Minnesota Oncology, Woodbury, MN, USA. · Univeristy of Wisconsin School of Medicine and Public Health, Madison, WI, USA. · Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA. · University of Colorado - Denver, Denver, CO, USA. · Columbia University Medical Center, New York, NY, USA. · Pubmed 27921276
  • University of Western Ontario, London. · Pulse Infoframe, London. · Health Outcomes and PharmacoEconomics (hope) Research Centre, Sunnybrook Research Institute, Toronto. · Sunnybrook Health Sciences Centre, Toronto. · Princess Margaret Hospital, Toronto; and. · London Regional Cancer Program, London, ON. · Pubmed 28680276
2016
  • Adil I. Daud, University of California, San Francisco, San Francisco · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA · Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, University of Pittsburgh, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ · Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia · Richard Kefford, Macquarie University · and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University · Peter Hersey, University of Sydney, Sydney, Australia · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · Adil Daud, University of California San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute · Antoni Ribas, University of California Los Angeles, Los Angeles, CA · Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France · Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA · Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada · Roxana Dronca, Mayo Clinic, Rochester, MN · Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ · and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • London Regional Cancer Program, London Health Sciences Centre, London, ON. · Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON. · Princess Margaret Cancer Centre, Toronto, ON. · Western University, London, ON. · Novartis Pharmaceuticals Canada Inc., Dorval, QC. · Pubmed 28050145
  • Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Clinical Discovery Unit, Early Clinical Development, AstraZeneca plc, DaVinci Building, Melbourn Science Park, Melbourn, Hertfordshire, UK. · Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada. · Department of Biostatistics, University Health Network, Toronto, Ontario, Canada. · Pubmed 27701388
  • Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Astrazeneca plc, Melbourn Science Park, DaVinci Building, Melbourn, United Kingdom. · Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia. · Pubmed 27683208
  • Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada. · Pubmed 26893783
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Pubmed 26822024
2015
  • Department of Medical Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9 Canada. · Merck & Co., Inc., Kenilworth, NJ USA. · Pubmed 26288737
2014
  • The Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ont. · The Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ont. · Pubmed 24549129
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York. · Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee. · Mayo Clinic, Rochester, Minnesota. · University of Iowa Hospital and Clinics, Iowa City. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · H. Lee Moffitt Cancer Center, Tampa, Florida. · Washington University, St Louis, Missouri. · University of Chicago, Chicago, Illinois. · Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · University of Michigan, Ann Arbor. · Metro Minnesota Community Clinical Oncology Program, St Louis Park. · University of Wisconsin, Madison. · Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. · University of Colorado, Aurora. · Investigational Drug Branch, National Cancer Institute, Rockville, Maryland. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24938562
  • University of Toronto Department of Ophthalmology and Vision Sciences, University Health Network/Toronto Western Hospital, 399 Bathurst Street, 6 East Room 415, Toronto, Ontario M5T 2S8 Canada. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 25516805
2016
  • From the *Department of Nuclear Medicine, Hamilton Health Sciences and St. Joseph's Healthcare Hamilton, McMaster University, Hamilton; †Department of Planning and Regional Programs, Planning Unit, Cancer Care Ontario; ‡Department of Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto; §Department of Clinical Programs, Cancer Imaging Program, Cancer Care Ontario; and ∥Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26447374
2015
  • aDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario bDepartment of Medical Oncology, Tom Baker Cancer Centre, Calgary cDepartment of Medical Oncology, Cross Cancer Institute, Edmonton, Alberta dDepartment of Medical Oncology, Royal Victoria Hospital, Montreal, Quebec, Canada. · Pubmed 26050146
2010
  • Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada. · Pubmed 21085676
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 31 total) written by Anthony M. Joshua about Melanoma:

  • Conjunctival Melanoma in Childhood and Adolescence: A Systematic Review. 2019
  • Immune checkpoint inhibitors in malignancy. 2019
  • Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2. 2019
  • Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. 2019
  • Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. 2019
  • Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. 2019
  • Oncogenic signaling in uveal melanoma. 2018
  • Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). 2018
  • Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma. 2018
  • Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. 2018
Show List of Full Article Records
Google Searches

Learn more about Anthony M. Joshua using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
St. Vincent's Hospital Sydney
University of New South Wales
University Health Network of Toronto
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
St. Vincent's Hospital Sydney
2019
  • Sydney Children's Hospital, Randwick, New South Wales, Australia. · School of Women's and Children's Health, University of New South Wales, Randwick, New South Wales, Australia. · St. Vincent's Hospital, Darlinghurst, New South Wales, Australia. · Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia. · Sydney Eye Hospital, Sydney, New South Wales, Australia. · Kid's Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia. · Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Pubmed 31768361
  • St Vincent's Hospital, Sydney. · St Vincent's Clinical School, UNSW Sydney. · Pubmed 31048940
  • Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Laboratory Medicine, University Health Network, Toronto, Canada. · Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Otolaryngology, Head and Neck Surgery, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Pharmacy, Princess Margaret Cancer Centre, Toronto, Canada. · Drug Development Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · University Health Network, Princess Margaret Cancer Centre, 9-622, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. · Pubmed 30747243
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. · Pubmed 29738114
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
2016
  • Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Astrazeneca plc, Melbourn Science Park, DaVinci Building, Melbourn, United Kingdom. · Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia. · Pubmed 27683208
2019
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. Electronic address: · Department of Dermatology, Gustave Roussy, Villejuif; Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead; Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, Macquarie University, Macquarie Park; Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Medical Oncology, University of Sydney, Sydney, Australia; Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, University of Sydney, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney; Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 31987275
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. · Department of Dermatology, Gustave Roussy, Villejuif. · Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead. · Medical Oncology, Melanoma Institute Australia, Sydney. · Medical Oncology, Macquarie University, Macquarie Park. · Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney. · Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 30715153
University of New South Wales
2019
  • St Vincent's Hospital, Sydney. · St Vincent's Clinical School, UNSW Sydney. · Pubmed 31048940
2018
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
2019
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. Electronic address: · Department of Dermatology, Gustave Roussy, Villejuif; Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead; Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, Macquarie University, Macquarie Park; Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Medical Oncology, University of Sydney, Sydney, Australia; Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, University of Sydney, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney; Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 31987275
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. · Department of Dermatology, Gustave Roussy, Villejuif. · Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead. · Medical Oncology, Melanoma Institute Australia, Sydney. · Medical Oncology, Macquarie University, Macquarie Park. · Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney. · Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 30715153
University Health Network of Toronto
2019
  • Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Laboratory Medicine, University Health Network, Toronto, Canada. · Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia. · Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Otolaryngology, Head and Neck Surgery, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Pharmacy, Princess Margaret Cancer Centre, Toronto, Canada. · Drug Development Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Immunology, University of Toronto, Toronto, Canada. · University Health Network, Princess Margaret Cancer Centre, 9-622, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. · Pubmed 30747243
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center · Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY · Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris · Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France · Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands · Stephen Frank, Hebrew University Hadassah Medical School - The Sharett Institute of Oncology, Jerusalem · Jacob Schachter, Sheba Medical Center at Tel Hashomer, and Tel-Aviv University Medical School, Tel Aviv, Israel · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Josep M. Piulats, Institut Catala d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Veronique Cocquyt, Ghent University Hospital, Ghent, Belgium · Bartosz Chmielowski, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA · T.R. Jeffry Evans, University of Glasgow, Glasgow · Delyth Clemett, Shirley Spratt, Susan Lovick, and Elaine Kilgour, AstraZeneca, Macclesfield · Dana Ghiorghiu and Gabriella Mariani, AstraZeneca, Cambridge · Paul Nathan, Mt Vernon Cancer Centre, Northwood, United Kingdom · Gerald Linette, Washington University School of Medicine, St Louis, MO · Carola Berking, University Hospital of Munich, Munich, Germany · Peter Barker, AstraZeneca, Gaithersburg, MD · and Zhongwu Lai, AstraZeneca, Waltham, MA. · Pubmed 29528792
  • Caroline Robert, Gustave Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Adil Daud, University of California, San Francisco, San Francisco, CA · Jedd D. Wolchok, Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY · Anthony M. Joshua, The Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H Lee Moffitt Cancer Center, Tampa · Richard W. Joseph, Mayo Clinic Cancer Center-Florida, Jacksonville, FL · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, UPMC Hillman Cancer Center, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead · Melanoma Institute Australia, Wollstonecraft · and Macquarie University, MQ Health, Health Sciences Centre · Peter Hersey, University of Sydney, Sydney, New South Wales, Australia · Jin Zhang, James Anderson, Scott J. Diede, and Scot Ebbinghaus, Merck & Co., Inc., Kenilworth, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 29283791
2017
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, NY, USA. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · Mayo Clinic, Rochester, MN, USA. · University of Iowa Carver College of Medicine, Iowa City, IA, USA. · Princess Margaret Hospital University Health Network, Toronto, ON, Canada. · Penn Medicine, Philadelphia, PA, USA. · University of Chicago, Chicago, IL, USA. · Mount Sinai Medical Center, Miami Beach, FL, USA. · University of Michigan, Ann Arbor, MI, USA. · Minnesota Oncology, Woodbury, MN, USA. · Univeristy of Wisconsin School of Medicine and Public Health, Madison, WI, USA. · Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA. · University of Colorado - Denver, Denver, CO, USA. · Columbia University Medical Center, New York, NY, USA. · Pubmed 27921276
  • University of Western Ontario, London. · Pulse Infoframe, London. · Health Outcomes and PharmacoEconomics (hope) Research Centre, Sunnybrook Research Institute, Toronto. · Sunnybrook Health Sciences Centre, Toronto. · Princess Margaret Hospital, Toronto; and. · London Regional Cancer Program, London, ON. · Pubmed 28680276
2016
  • Adil I. Daud, University of California, San Francisco, San Francisco · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA · Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, University of Pittsburgh, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ · Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia · Richard Kefford, Macquarie University · and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University · Peter Hersey, University of Sydney, Sydney, Australia · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · Adil Daud, University of California San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute · Antoni Ribas, University of California Los Angeles, Los Angeles, CA · Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France · Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA · Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada · Roxana Dronca, Mayo Clinic, Rochester, MN · Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ · and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • London Regional Cancer Program, London Health Sciences Centre, London, ON. · Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON. · Princess Margaret Cancer Centre, Toronto, ON. · Western University, London, ON. · Novartis Pharmaceuticals Canada Inc., Dorval, QC. · Pubmed 28050145
  • Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Clinical Discovery Unit, Early Clinical Development, AstraZeneca plc, DaVinci Building, Melbourn Science Park, Melbourn, Hertfordshire, UK. · Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada. · Department of Biostatistics, University Health Network, Toronto, Ontario, Canada. · Pubmed 27701388
  • Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Astrazeneca plc, Melbourn Science Park, DaVinci Building, Melbourn, United Kingdom. · Princess Margaret Cancer Centre, 610 University Avenue. M5G2M9, Toronto, Canada. · Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia. · Pubmed 27683208
  • Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada. · Pubmed 26893783
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Pubmed 26822024
2015
  • Department of Medical Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9 Canada. · Merck & Co., Inc., Kenilworth, NJ USA. · Pubmed 26288737
2014
  • The Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ont. · The Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ont. · Pubmed 24549129
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York. · Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee. · Mayo Clinic, Rochester, Minnesota. · University of Iowa Hospital and Clinics, Iowa City. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · H. Lee Moffitt Cancer Center, Tampa, Florida. · Washington University, St Louis, Missouri. · University of Chicago, Chicago, Illinois. · Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · University of Michigan, Ann Arbor. · Metro Minnesota Community Clinical Oncology Program, St Louis Park. · University of Wisconsin, Madison. · Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. · University of Colorado, Aurora. · Investigational Drug Branch, National Cancer Institute, Rockville, Maryland. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24938562
  • University of Toronto Department of Ophthalmology and Vision Sciences, University Health Network/Toronto Western Hospital, 399 Bathurst Street, 6 East Room 415, Toronto, Ontario M5T 2S8 Canada. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 25516805
2016
  • From the *Department of Nuclear Medicine, Hamilton Health Sciences and St. Joseph's Healthcare Hamilton, McMaster University, Hamilton; †Department of Planning and Regional Programs, Planning Unit, Cancer Care Ontario; ‡Department of Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto; §Department of Clinical Programs, Cancer Imaging Program, Cancer Care Ontario; and ∥Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26447374
2015
  • aDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario bDepartment of Medical Oncology, Tom Baker Cancer Centre, Calgary cDepartment of Medical Oncology, Cross Cancer Institute, Edmonton, Alberta dDepartment of Medical Oncology, Royal Victoria Hospital, Montreal, Quebec, Canada. · Pubmed 26050146
2010
  • Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada. · Pubmed 21085676
Miscellaneous institutions in Sydney
2019
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Division of Dermatology, University of Toronto. · Departments of Medical Oncology and Hematology. · Clinical Discovery Unit, Early Clinical Development, iMED Biotech Unit, Melbourn, UK. · Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincents Hospital. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 30067547
Mater Hospital
2018
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. · Pubmed 29738114
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
2019
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. Electronic address: · Department of Dermatology, Gustave Roussy, Villejuif; Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead; Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, Macquarie University, Macquarie Park; Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Medical Oncology, University of Sydney, Sydney, Australia; Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Medical Oncology, Melanoma Institute Australia, Sydney; Medical Oncology, University of Sydney, Sydney, Australia; Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney; Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 31987275
  • Medical Oncology, The Angeles Clinic and Research Institute, Los Angeles, USA. · Department of Dermatology, Gustave Roussy, Villejuif. · Department of Medicine, University of Paris-Sud, Paris, France. · Department of Medicine, University of California, San Francisco, San Francisco. · Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. · Medical Oncology, Westmead Hospital, Westmead. · Medical Oncology, Melanoma Institute Australia, Sydney. · Medical Oncology, Macquarie University, Macquarie Park. · Medical Oncology, University of Sydney, Sydney, Australia. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Centenary Institute, Sydney, Australia. · Medical Oncology, Mayo Clinic Cancer Center-Florida, Jacksonville. · Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York. · Division of Hematology Oncology, Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia. · Medical Oncology, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Kinghorn Cancer Centre, St. Vincent's Hospital, Medical Oncology, Garvan Institute of Medical Research, Sydney. · Medical Oncology, University of New South Wales, Sydney, Australia. · Merck & Co., Inc., Kenilworth. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. · Pubmed 30715153
Unspecified
2018
  • Division of Dermatology, University of Toronto. · Departments of Medical Oncology and Hematology. · Clinical Discovery Unit, Early Clinical Development, iMED Biotech Unit, Melbourn, UK. · Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincents Hospital. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 30067547
10 Other Locations Show
Yearly article counts 06529241101
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.